1 / 4

Spinal Cord Injury Therapeutics Market Analysis, 2020 - 2027

Spinal cord injuries are the injuries caused to the thirty one pairs of spinal nerves, which carry nerve signals from brain to various parts of the body and also controls the arms and leg movements. The main cause of spinal cord injuries include trauma, loss of blood supply to spinal cord, and compression in spinal cord due to tumor or infections. Spinal cord injuries can be diagnosed with the help of various techniques such as X-ray, magnetic resonance index (MRI), and computed tomography (CT).

akshay925
Download Presentation

Spinal Cord Injury Therapeutics Market Analysis, 2020 - 2027

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Spinal Cord Injury Therapeutics Market, by Injury Type Spinal Cord Injury Therapeutics Market, by Injury Type (Complete Spinal Cord Injury and Incomplete Spinal Cord (Complete Spinal Cord Injury and Incomplete Spinal Cord Injury), by Drug Type (Corticosteroids, Muscle Relaxants Injury), by Drug Type (Corticosteroids, Muscle Relaxants and Anti-spastic drugs, Non-steroidal Anti-inflammatory and Anti-spastic drugs, Non-steroidal Anti-inflammatory drugs ( NSAID’S), Anti-depressants, Anticonvulsants, and drugs ( NSAID’S), Anti-depressants, Anticonvulsants, and Others), by Application (Autonomic Dysreflexia (AD), Others), by Application (Autonomic Dysreflexia (AD), Spasticity & Inflammation, Pain Management, and Spasticity & Inflammation, Pain Management, and Depression), by Route of Administration (Oral and Depression), by Route of Administration (Oral and Intravenous), by Distribution Channel (Hospital Intravenous), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 -2027 Outlook, and Opportunity Analysis, 2020 -2027 Spinal cord injuries are the injuries caused to the thirty one pairs of spinal nerves, which carry nerve signals from brain to various parts of the body and also controls the arms and leg movements. The main cause of spinal cord injuries include trauma, loss of blood supply to spinal cord, and compression in spinal cord due to tumor or infections. Spinal cord injuries can be diagnosed with the help of various techniques such as X-ray, magnetic resonance index (MRI), and computed tomography (CT).

  2. The global spinal cord injury therapeutics market is estimated to be valued at US$ 6,630.7 million in 2020 and is expected to exhibit a CAGR of 6.7% during the forecast period (2020-2027). Get PDF Brochure Of This Research Report @ https://www.coherentmarketinsights.com/insight/request-pdf/4305 Increasing prevalence of traumatic spinal cord injuries is expected to propel growth of the global spinal cord injuries therapeutics market during the forecast period. For instance, according to the US National Library of Medicine report published in 2018, stated that the prevalence of traumatic spinal cord injuries in low and middle economic economies such as Algeria, Bangladesh etc was 8.72 % per 100,000 individuals and prevalence of traumatic spinal cord injuries in high income countries such as Bermuda (UK), Switzerland and others was 13.69 % per 100,000 individuals, globally in the year 2018. Furthermore, key companies focusing on research and development in the treatment of spinal cord injury is expected to propel growth of the global spinal cord injury therapeutics market during the forecast period. For instance, in July 2017, ReNetX Bio, licensed the rights of the innovative neuro-restorative Nogo Receptor platform technology developed at Yale University. The central nervous system contains major extracellular factors that limit the regrowth of neurons. The university developed a decoy receptor, called Nogo Trap that binds the growth inhibitors allowing the body to grow nerve fibers naturally. Global Spinal Cord Injury Therapeutics Market – Impact of Coronavirus (COVID-19) Following the outbreak of COVID-19 in December 2019, the disease has spread to over 100 countries across the globe and the World Health Organization declared it a public health emergency. According to the World Health Organization’s report, manifestation of coronavirus (COVID-19) has resulted in over 60.9 million infected individuals worldwide as of 27th November, 2020. Covid-19 pandemic has affected the spinal cord injury therapeutics market negatively in various ways such as shortage of personal healthcare attendant and health care treatments for individuals suffering from spinal cord injuries. Therefore

  3. various academic institutes and companies are taking initiatives to combat various difficulties faced by individuals such as shortage of personal healthcare attendant and health care treatments for individuals suffering from spinal cord injuries during the COVID-19 pandemic. For instance, in May 2020, United Spinal Association, a nonprofit membership, disability rights, and veterans service organization initiated one on one assistance provided by United Spinal’s team of information specialists to the individuals suffering from spinal cord injuries and various difficulties faced by them due to COVID-19 pandemic. North America is expected to hold dominant position in the global spinal cord injuries therapeutics market during the forecast period, owing to key companies focusing on research and development for the treatment of spinal cord injury. For instance, in 2018, Vertex Pharmaceuticals Incorporated, a U.S.-based biopharmaceutical company completed the investigational clinical trial study on the safety and efficacy of VX-210 in 70 subjects with acute traumatic cervical spinal cord injury and also had secondary objective, which included the specific evaluation of the effects of VX-210 on neurological recovery and daily function after spinal cord injury. Research Methodology Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include: Primary Research (Trade Surveys and Experts Interviews) • Desk Research • Proprietor Data Analytics Model • In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.

  4. Request Sample Copy of Research Report @ https://www.coherentmarketinsights.com/insight/request-sample/4305 Key Players Major players operating in the global spinal cord injury therapeutics market include ReNetX Bio, InVivo Therapeutics Hldg, GTX Medical, Acorda Therapeutics, Lineage Cell Therapeutics, AbbVie Inc., Asterias Biotherapeutics, Inc, BioArctic, Kringle Pharma, Inc., Pfizer Inc., Pharmicell Co., Ltd., Bioaxone Biosciences, Inc., Vertex Pharmaceuticals Inc., Biogen Inc., RespireRx Phamaceuticals Inc., NervGen, Lannett Co Inc, Teva Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories, MSN Laboratories Private Limited, Rising Pharmaceuticals, Inc., ScieGen Pharmaceuticals, Inc, and Cadila Healthcare Limited. About Coherent Market Insights Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. Contact Us Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: +1-206-701-6702 Email: sales@coherentmarketinsights.com

More Related